GEMPHIRE THERAPEUTICS INC.

Company

MetaVia Inc.

Filed

March 20, 2017

Accession Number

0000902664-17-001681

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →